Skip to main content
. 2019 May 17;36(7):1672–1683. doi: 10.1007/s12325-019-00964-z

Table 3.

Hazard ratios [95% CI] for the risk of developing secondary IMIDs

Initial IMID Secondary IMIDa
N AS CE HS LU PsA PsO RA UV IBD Any 1 Any 2
AS 4,065,648 11.2 3.3 23.7 50.8 8.6 63.2 54.9 16.0 31.4 35.7
[–, –] [8.0, 15.5] [1.5, 7.0] [19.8, 28.3] [43.7, 59.0] [7.4, 10.1] [58.6, 68.2] [48.5, 62.3] [13.5, 19.0] [29.7, 33.1] [31.2, 40.7]
CE 11,539,665 4.0 4.0 8.7 2.8 5.4 6.0 5.3 17.6 7.8 4.5
[2.7, 6.2] [–, –] [2.9, 5.6] [7.5, 10.0] [2.0, 3.8] [4.8, 6.0] [5.4, 6.6] [4.3, 6.4] [16.0, 19.3] [7.4, 8.3] [3.8, 5.4]
HS 8,461,932 4.4 3.2 4.1 2.7 6.7 4.6 5.3 5.6 5.4 3.0
[2.7, 7.1] [2.3, 4.6] [–, –] [3.2, 5.2] [1.8, 4.1] [5.9, 7.6] [4.0, 5.3] [4.2, 6.8] [4.7, 6.7] [5.0, 5.8] [2.3, 3.8]
LU 19,842,102 15.5 11.5 7.5 7.8 5.1 41.8 9.7 7.0 18.9 10.0
[13.1, 18.3] [10.1, 13.1] [6.1, 9.1] [–, –] [6.7, 9.1] [4.6, 5.5] [40.5, 43.2] [8.7, 10.8] [6.3, 7.8] [18.4, 19.4] [9.1, 11.0]
PsA 5,389,121 71.4 5.3 10.5 14.1 163.2 91.5 10.0 7.3 62.2 75.2
[60.2, 84.6] [3.6, 7.7] [7.3, 15.1] [11.8, 16.8] [–, –] [155.0, 171.9] [86.4, 96.9] [8.1, 12.2] [5.9, 8.9] [59.9, 64.6] [69.3, 81.7]
PsO 74,343,272 5.8 5.5 8.5 4.7 197.3 7.9 4.5 4.1 13.0 14.3
[5.1, 6.7] [5.0, 6.1] [7.7, 9.4] [4.3, 5.1] [191.8, 203.0] [–, –] [7.6, 8.2] [4.1, 4.8] [3.9, 4.4] [12.7, 13.2] [13.7, 15.0]
RA 68,911,818 78.5 10.3 8.1 55.3 46.9 7.2 8.2 7.6 16.8 14.0
[74.1, 83.1] [9.5, 11.1] [7.2, 9.1] [53.7, 57.0] [45.0, 48.9] [6.9, 7.5] [–, –] [7.7, 8.8] [7.2, 8.0] [16.5, 17.1] [13.3, 14.7]
UV 22,200,869 89.3 4.8 6.9 8.6 5.5 4.2 11.1 8.7 9.6 9.6
[82.6, 96.7] [3.9, 5.8] [5.6, 8.6] [7.7, 9.5] [4.6, 6.4] [3.8, 4.6] [10.6, 11.8] [–, –] [8.0, 9.6] [9.3, 9.9] [8.7, 10.5]
IBD 42,440,304 13.4 15.1 8.0 5.6 2.3 5.0 7.4 10.2 7.5 4.6
[11.8, 15.3] [13.9, 16.4] [7.0, 9.1] [5.1, 6.1] [1.9, 2.8] [4.7, 5.3] [7.1, 7.8] [9.5, 11.0] [–, –] [7.3, 7.8] [4.2, 5.1]

Hazard of developing a secondary IMID condition for case patients relative to control patients conditional on being in the initial IMID condition sample. Ratios above 1 indicate a higher risk for case patients than control patients

aSecondary IMIDs were identified by presence of at least one claim with an ICD-9 diagnosis code for that secondary IMID